North American Report

Regular COVID-19 testing made easy with INDICAID® COVID-19 Rapid Antigen Test.

 Breaking News
  • No posts were found

Regular COVID-19 testing made easy with INDICAID® COVID-19 Rapid Antigen Test.

August 19
19:51 2022
Omicron Subvariants BA.4 and BA.5 account for 70% of infections in the US. Residents must continue the fight against COVID-19 and its variants regardless of vaccination status.

The US is still grappling with the COVID-19 pandemic, and the most recent wave of Omicron infections is cause for concern. The alarming transmission rate of Omicron and its subvariants, ease of infection, and resistance to COVID-19 vaccines have left many wondering how best to protect themselves and their loved ones.

The Center for Disease Control and Prevention revealed that the BA.4 and BA.5 subvariants are estimated to make up 70.1% of all COVID infections in the US. BA.4 accounts for 16.5% and BA.5 up to 53.6%. Since the Omicron variant was discovered in late 2021, its variants have been detected in more than 95 countries.

Understanding the symptoms of Omicron

Much like other COVID-19 variants, the symptoms of Omicron and its subvariants are quite similar. However, the severity of these symptoms differs from person to person. In addition to other symptoms of Coronavirus, the most recognizable symptoms of Omicron are:

–  Headaches
–  Runny nose
–  Sneezing
–  Mild or severe fatigue
–  Sore throat

How to fight against the fast-spreading BA.4 and BA.5 Omicron subvariants

Part of the alarm about the BA.4 and BA.5 Omicron subvariants is their resistance to the COVID-19 vaccines. Getting booster shots in addition to the two doses of vaccines is more effective against Omicron; however, it doesn’t provide complete protection.

With chances of infection even after vaccination, people must continue to practice COVID-19 protection measures like:
–  At-home testing
–  Washing hands regularly and properly
–  Wearing masks in highly infected areas
–  Social distancing
–  Avoiding large gatherings 

Regular testing with INDICAID® COVID-19 Rapid Antigen Test 

Testing regularly is the best way to stay protected and catch any infections early. It is made easy and convenient with INDICAID® COVID-19 Rapid Antigen Test, an at-home self-test that is especially handy for people who often attend large gatherings, work, and travel. The test is easy to use and provides easy to read results in 20 minutes. 

INDICAID® COVID-19 Rapid Antigen Test is FDA authorized under a EUA and globally recognized. The accurate, rapid test is recognized in more than 30 countries, and 45+ million tests have been sold worldwide.

–  Approved by FDA EUA
–  93.4% overall accuracy
–  Able to detect virus variants (incl. Delta & Omicron)
–  HSA/FSA Eligible 

This COVID-19 self-protection test is affordable, reliable, non-invasive, and suitable for everyone aged two years and above. The test works for symptomatic and asymptomatic individuals. It is available OTC and can be ordered online, where fast delivery is guaranteed.

Media Contact
Company Name: PHASE Scientific International Limited
Email: Send Email
Country: United States
Website: https://indicaidusa.com/